HUTCHMED will bring a broad slate of oncology and hematology readouts to ESMO Asia (December 5–7, Singapore) and ASH...

Orchestra BioMed granted stock options covering 151,250 shares to 12 newly hired employees on November 24 under its 2025...

BioVersys has dosed the first healthy volunteer in a China-based Phase 1 study of BV100, an intravenous rifabutin formulation...

Orchestra BioMed has issued stock options for 151,250 shares to 12 new hires under a Nasdaq-compliant inducement plan, with...

SciSparc has signed a binding term sheet to acquire a portfolio of patents, trademarks, and know-how from Xylo Technologies,...

Tangram Therapeutics has submitted a Clinical Trial Application to the UK’s MHRA for TGM-312, a GalNAc-conjugated siRNA targeting a...

Nurexone Biologic reported a busy third quarter: the exosome-focused biotech secured roughly C$4.6 million in fresh capital through accelerated...

PolyPid will host a virtual KOL event on December 10 to spotlight D-PLEX100, its locally delivered doxycycline depot designed...

CytomX Therapeutics will present at two December investor conferences—the Evercore Healthcare Conference on December 2 and the Piper Sandler...

Tangram Therapeutics has submitted a Clinical Trial Application to the UK MHRA to initiate a Phase 1/2 study of...